enVVeno Medical (NVNO) Preferred Stock Liabilities (2017)
enVVeno Medical has reported Preferred Stock Liabilities over the past 1 years, most recently at $1.2 million for Q4 2017.
- Quarterly results put Preferred Stock Liabilities at $1.2 million for Q4 2017, changed N/A from a year ago — trailing twelve months through Dec 2017 was $1.2 million (changed N/A YoY), and the annual figure for FY2017 was $1.2 million, changed.
- Preferred Stock Liabilities for Q4 2017 was $1.2 million at enVVeno Medical.
- Over the last five years, Preferred Stock Liabilities for NVNO hit a ceiling of $1.2 million in Q4 2017 and a floor of $1.2 million in Q4 2017.